Nasopharyngeal News and Research

RSS
Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Researchers discover evolutionary nature of bacteria to spread chronic infectious disease

Fluctuation in PCV-7 vaccine dosing time increases pneumococcal serotype 19A strains: Study

Fluctuation in PCV-7 vaccine dosing time increases pneumococcal serotype 19A strains: Study

Genta presents tesetaxel dose-ranging trial results at ASCO 2010

Genta presents tesetaxel dose-ranging trial results at ASCO 2010

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

FDA issues 510(k) clearance to Simplexa Influenza A H1N1 (2009) test on 3M Integrated Cycler

FDA issues 510(k) clearance to Simplexa Influenza A H1N1 (2009) test on 3M Integrated Cycler

New study shows DFA testing for H1N1 influenza unreliable in ICU patients

New study shows DFA testing for H1N1 influenza unreliable in ICU patients

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

FDA grants EUA for IQuum's Liat Influenza A/2009 H1N1 Assay

FDA grants EUA for IQuum's Liat Influenza A/2009 H1N1 Assay

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

FDA grants Diagnostic Hybrids emergency use authorization for 2009 H1N1 Influenza A Virus ID Kit

Principio, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center sign technology licensing agreement

Principio, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center sign technology licensing agreement

Idaho Technology commences clinical trials of FilmArray RP

Idaho Technology commences clinical trials of FilmArray RP

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

Presence of Streptococcus pneumoniae could predict risk of severe disease in H1N1 pandemic influenza

Second wave of H1N1 virus infection in the U.S. comes to an end

Second wave of H1N1 virus infection in the U.S. comes to an end

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Advanced radiation delivery techniques can reduce TomoTherapy treatment time

Advanced radiation delivery techniques can reduce TomoTherapy treatment time

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark